Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov-Dec;94(6):759-761.
doi: 10.1016/j.abd.2018.12.004. Epub 2019 Oct 26.

Second neoplasms associated with primary cutaneous lymphomas

María Encarnación Gómez Sánchez  1 , Maria Rodríguez Vázquez  2 , Manuela Mollejo Villanueva  3
Affiliations

Second neoplasms associated with primary cutaneous lymphomas

María Encarnación Gómez Sánchez et al. An Bras Dermatol. 2019 Nov-Dec.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Primary cutaneous lymphoma and second neoplasms according to origin of T/B lineage. PCTCLs, primary cutaneous t-cell lymphoma; PCBC-L, primary cutaneous b-cell lymphoma; BPDCN, blastic plasmacytoid dendritic cell neoplasm.
Figure 2
Figure 2
Frequency of second neoplasm according to subtypes of PCL. MF, mycosis fungoides; LyP, lymphomatoid papulosis; C-ALCL, cutaneous anaplastic large-cell lymphoma; SS, Sezary syndrome; PCMZL, primary cutaneous marginal zone lymphoma; PCFCL, primary cutaneous follicle center lymphoma; PCDLBL-TP, primary cutaneous diffuse large b-cell lymphoma; BPDCN, blastic plasmacytoid dendritic cell neoplasm.
See this image and copyright information in PMC

References

    1. Vardiman J.W., Thiele J., Arber D.A., Brunning R.D., Borowitz M.J., Porwit A. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937–951. - PubMed
    1. Brownell I., Etzel C.J., Yang D.J., Taylor S.H., Duvic M. Increased malignancy risk in the cutaneous T-cell lymphoma patient population. Clin Lymphoma Myeloma. 2008;8:100–105. - PubMed
    1. Amber K.T., Bloom R., Nouri K. Second primary malignancies in CTCL patients from 1992 to 2011: a SEER-based, population-based study evaluating time from ctcl diagnosis, age, sex, stage, and CD30+ subtype. Am J Clin Dermatol. 2016;17:71–77. - PubMed
    1. Chan S.A., Shah F., Chaganti S., Stevens A., Amel-Kashipaz R., Vydianath B. Primary cutaneous B-cell lymphoma: systemic spread is rare while cutaneous relapses and secondary malignancies are frequent. Br J Dermatol. 2017;177:287–289. - PubMed
    1. Morton L.M., Curtis R.E., Linet M.S., Bluhm E.C., Tucker M.A., Caporaso N. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype. J Clin Oncol. 2010;28:4935–4944. - PMC - PubMed